MétaCan
Menu
Back to cohort

Baseline circulating growth differentiation factor-15 and the cancer phenotype in the PROACC-1 phase 2 study of the efficacy and safety of ponsegromab in patients with cancer cachexia.

2025· article· en· W4410795441 on OpenAlexaff
Eric Roeland, Susie M. Collins, Shelley des Etages-Wong, Shannon L. Lubaczewski, Tateaki Naito, Andrew Hendifar, Marie Fallon, Koichi Takayama, Timothy R. Asmis, Richard F. Dunne, Ira Jacobs, Michelle I. Rossulek, Ruolun Qiu, Jeffrey Crawford, Aditi R. Saxena, John D. Groarke

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicGDF15 and Related Biomarkers
Canadian institutionsOttawa Hospital
Fundersnot available
KeywordsMedicineCancerCancer cachexiaCachexiaOncologyInternal medicinePhenotypeCancer researchGeneBiologyGenetics

Abstract

fetched live from OpenAlex

12060 Background: Growth differentiation factor-15 (GDF-15) is an emerging therapeutic target in cancer cachexia. However, the association of circulating GDF-15 with the cancer cachexia phenotype remains poorly characterized. Methods: Serum GDF-15 was measured using the Roche Elecsys GDF-15 assay at screening in a phase 2, randomized trial of ponsegromab (an investigational anti-GDF-15 monoclonal antibody) in patients with cancer cachexia, and an elevated serum GDF-15 (≥ 1500 pg/mL) (NCT05546476). Cachexia was defined by international consensus criteria and sarcopenia by standardized sex-specific cut-off values for lumbar skeletal muscle index. Cross-sectional associations of GDF-15 with various demographic and clinical parameters were explored post-hoc using summary statistics and Pearson’s correlation (with GDF-15 on the log 10 scale). Results: A total of 187 patients were enrolled in this study with a median (IQR) age of 67 (60-74) years and 37% were female. Baseline median GDF-15 values were higher among patients with cachexia and colorectal and pancreatic cancers, compared to NSCLC. GDF-15 elevation was higher in patients with stage IV disease, sarcopenia, and worse performance status (Table). Higher GDF-15 levels were associated with lower serum albumin (r = -0.31 [95% CI: -0.44, -0.177]) and pre-albumin (r = -0.17 [95% CI: -0.31, -0.03]). No significant associations were observed between GDF-15 levels and appetite or fatigue assessments. Conclusions: Among patients with cancer cachexia, GDF-15 elevation was more pronounced in those with more advanced cancer, sarcopenia, and worse performance status. In addition, GDF-15 levels were negatively correlated with markers of nutritional status. Clinical trial information: NCT05546476 . Demographic or Clinical Characteristic n Median (IQR) serum GDF-15, pg/ml Age, years- 18-44- 45-64- ≥65 670111 2718 (2461, 8117)4197 (2366, 9425)3849 (2310, 7125) Type of cancer- NSCLC- Pancreatic- Colorectal 745954 2701 (2114, 4094)4714 (2408, 9561)6468 (4106, 10052) Interval from cancer diagnosis- <1 year- ≥1 year 9691 4259 (2447, 8919)3781 (2259, 6997) Stage of cancer- I/II- III- IV 1634137 3551 (2264, 6320)3232 (2461, 5704)4365 (2387, 8117) Body mass index (BMI), kg/m2- <20- ≥20 9988 3254 (2220, 6801)5052 (2712, 8749) % weight loss in 6 months prior to screening- < 10%- ≥ 10% 9988 3849 (2290, 7677)4118 (2381, 7595) Sarcopenia status- Yes- No 14440 4259 (2402, 7672)2928 (2136, 8052) ECOG Performance Status- 0- 1- 2/3 3312331 2842 (2408, 5673)4094 (2366, 8623)5119 (2272, 7667) Systemic anticancer therapy- Platinum-based therapy- Antimetabolite agents- Biological agents- Antimicrotubule agents- PD-1 or PD-L1 inhibitors 68100407330 5760 (3053, 10008)5914 (2847, 10768)5744 (3317, 9644)4891 (2762, 9425)2744 (2149, 4787)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.002
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.047
Threshold uncertainty score0.277

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0020.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.045
GPT teacher head0.418
Teacher spread0.373 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical OncologySame topicGDF15 and Related BiomarkersFrench-language works237,207